Xencor (XNCR) Stock: Buy, Sell, or Hold?

XNCR - Xencor, Inc.

PHARMACEUTICAL PREPARATIONS
$24.84
0.07 (0.28%) ▲
5d: +4.37%
30d: -7.66%
90d: +66.82%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026

Get Alerted When XNCR Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: XNCR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: XNCR is currently trading at $24.84, which is considered fair relative to its 30-day fair value range of $24.10 to $27.58.

Technical Outlook: Technically, XNCR is in a strong uptrend. Immediate support is located at $23.30, while resistance sits at $26.35.

Market Sentiment: XNCR scores 66/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $31.42 (+26.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $24.10 - $27.58
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 86.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (66/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 26.5% below Wall St target ($31.42)
  • CAUTION: Bottoming setup, but lagging the sector by 21% over 20 days — wait for relative strength

Trading Range Analysis

30-Day Trading Range $24.10 - $27.58
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $23.31
Resistance Level $26.35
Current Trend Strong Uptrend
Technical data as of Oct 2, 2026

Fundamental Context

Forward P/E (Next Year Est.) -6.99
Wall Street Target $31.42 (+26.5%)
Revenue Growth (YoY) 17.5%
Profit Margin -155.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: October 03, 2026 7:36 AM ET
Data refreshes hourly during market hours. Next update: 8:36 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for XNCR.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
29 analysts
$92 46 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$36 65 BUY
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$109 76 BUY
NRIX
Nurix Therapeutics Inc
STRONG BUY
18 analysts
$34 65 BUY
SRRK
Scholar Rock Holding Corp
STRONG BUY
10 analysts
$70 68 BUY

More Analysis for XNCR

XNCR Technical Chart XNCR Price Prediction XNCR Earnings Date Why is XNCR Moving Today? XNCR Investment Advisor XNCR Fair Price Analyzer XNCR Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals